Research and Development

Showing 15 posts of 9596 posts found.

First-in-class cancer treatment Vidaza launched

March 3, 2009 Research and Development Vidaza

Vidaza, an innovative new treatment for a number of hard-to-treat blood cancers, has been launched in the UK by Celgene. …

Chinese move marks ‘globalisation’ of Bayer Schering R&D

March 2, 2009 Research and Development Asia, Bayer, China

Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …

Novartis vaccine recalled after contamination scare

February 26, 2009 Manufacturing and Production, Research and Development Vaccine

Novartis has recalled UK supplies of its meningitis C vaccine after tests found some batches contaminated with bacteria. The recall …

Time running out for pharma sales and marketing

February 26, 2009 Research and Development, Sales and Marketing pwC, strategy

The pharma industry's current sales and marketing model will be defunct in the next ten years. That is the stark …

Europe approves Lilly’s Plavix rival

February 25, 2009 Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …

NovaBiotics: a rising star for 2009

February 24, 2009 Research and Development NovaBiotics

Biologics company NovaBiotics has been dubbed a Rising Star for 2009 by the Scottish arm of the BioIndustry Association. The …

R&D tax credits among anticipated changes for US healthcare

February 24, 2009 Research and Development US, healthcare

With the election of Barack Obama, widespread changes are anticipated for US healthcare and ultimately for the pharmaceutical industry. Although …

Bringing global trials teams together

February 23, 2009 Research and Development clinical trials, global

The world is getting bigger and smaller at the same time. When the internet began to really catch on about …

Raptiva suspended in Europe over safety concerns

February 20, 2009 Research and Development, Sales and Marketing Europe, Rapitva

Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …

Servier claims victory over NICE in osteoporosis

February 19, 2009 Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …

GSK’s diabetes candidate enters phase III

February 19, 2009 Research and Development GSK, diabetes

A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …

Genzyme says new plant approval is imminent

February 18, 2009 Research and Development, Sales and Marketing Genzyme

Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …

Lilly to boost biotech stake in NeuroSearch deal

February 17, 2009 Research and Development Denmark, Europe, NeuroSearch

Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …
The Gateway to Local Adoption Series

Latest content